美股市場個股詳情

CMND Clearmind Medicine

添加自選

1.1701
-0.0099-0.84%

收盤價 05/02 16:00 (美東)

1.2100
+0.0399+3.41%

盤後 17:41 (美東)

381.63萬總市值-62市盈率TTM

Clearmind Medicine股票討論區

登錄發表評論

DDDDDDDDDDD

昨天 00:33

$Clearmind Medicine(CMND.US)$ University of Washington Shrooms

DDDDDDDDDDD

05/01 21:24

$Safe & Green Development(SGD.US)$ and $Clearmind Medicine(CMND.US)$ MUSHROOM AND SEE THINGS LMFAO

DDDDDDDDDDD

04/30 20:32

$Clearmind Medicine(CMND.US)$ and $Sunshine Biopharma(SBFM.US)$ LFG

DDDDDDDDDDD

04/30 09:36

$Clearmind Medicine(CMND.US)$ Who's coming with me

DDDDDDDDDDD

04/30 01:04

$Clearmind Medicine(CMND.US)$ and $reAlpha Tech(AIRE.US)$ PSYCHEDELICS and AI

Stock Region

04/18 03:05

Biotechnology Company Announces Exclusive Licensing Agreement For Mental Disorder Treatment

The Dawn of a New Era in Mental Health Treatment: Clearmind Medicine's Revolutionary Psychedelic Compounds.
Clearmind Medicine Inc., has recently announced an exclusive licensing agreement that could fundamentally transform the landscape of mental health therapy. This partnership with Yissum Research Development Company of the Hebrew University of Jerusalem heralds the arrival of generation 3.0 psychedelic...

Trytosaveabit

04/17 19:58

Update

$Clearmind Medicine(CMND.US)$ Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

Trytosaveabit

04/10 19:26

Update

$Clearmind Medicine(CMND.US)$ Clearmind Medicine Announced That It Has Filed A Patent Application With United States Patent And Trademark Office For Psychedelic-based Treatment For Eating Disorders

Trytosaveabit

04/09 20:15

Interesting !

$Clearmind Medicine(CMND.US)$ Clearmind Medicine CEO Issues Letter To Shareholders; Says Poised To Achieve Significant Milestones That It Hopes To Substantially Enhance Shareholder Value Through 2024

Trytosaveabit

03/21 02:53

Update

$Clearmind Medicine(CMND.US)$$Cybin(CYBN.US)$$Bright Minds Biosciences(DRUG.US)$$ATAI Life Sciences(ATAI.US)$ Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Benzinga· 2 mins ago

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度